3D APT

MR Clinical applications

Find similar products

3D APT (Amide Proton Transfer)¹⁻³ is a unique, contrast-free, brain MR imaging method addressing the need for more confident diagnosis in neuro oncology. 3D APT uses the presence of endogenous cellular proteins, to produce an MR signal that directly correlates with cell proliferation, a marker of tumoral activity. 3D APT can support trained medical professionals in differentiating low grade from high grade gliomas and, in differentiating tumor progression from treatment effect⁴,⁵

*

Contact information

* This field is mandatory

*
*
*
*
*
*
*
*
*

By specifying your reason for contact we will be able to provide you with a better service.

We work with partners and distributors who may contact you about this Philips product on our behalf.

*
*

Final CEE consent

Philips MR 3D APT

 

Enhanced diagnostic confidence in MR neuro oncology

mr banner
  • 1 Zhou et al.,Nat Med 9, 1085-1090 (2003).
  • 2 Zhou et al., Magn Reson Med 50, 1120-1126 (2003)
  • 3 Jones et al., Magn Reson Med 56, 585-592 (2006).
  • 4 Togao et al. (2014) Neuro-Oncology
  • 5 Park KJ et al. (2016) Eur Radiol

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

You are entering a Philips Healthcare Australia website
Please select the checkbox

The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).

By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.